Entering text into the input field will update the search result below

Bristol-Myers down 2% premarket on late-stage results from kidney cancer study; rival Exelixis up 3%

Recommended For You

About BMY Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
BMY--
Bristol-Myers Squibb Company